Home
Sanofi Pasteur SA

Sanofi Pasteur SA Market Share Analysis for June 2026

Learn about immunology and chronic inflammatory conditions, and how Sanofi supports patients with science-based solutions.

Health > Biotechnology and Pharmaceuticals

Domainsanofipasteur.com

Year Founded2004

Employees> 10001

Annual Revenue> $1B

Sanofi Pasteur SA

Sanofi Pasteur SA (including company regionals)

sanofipasteur.com

See more website traffic and engagement information

Sanofi Pasteur SA Revenue up to June 2026 is > 1B

revenue generated by Sanofi Pasteur SA top domains

Sanofi Pasteur SA top domains revenue over 3 years

Revenue for Sanofi Pasteur SA top domains

sanofipasteur.com> 1B

See more with Sales Intelligence

Total visits to Sanofi Pasteur SA's top domains

Understand Sanofi Pasteur SA market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Sanofi Pasteur SA's top domains

Analyze Sanofi Pasteur SA engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Sanofi Pasteur SA's top domains

See how Sanofi Pasteur SA keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Sanofi Pasteur SA top competitors by domain

Top similar sites in June 2026, ranked by their affinity

zentiva.comCompany NameZentivaEmployees5001 - 10000HQCzech Republic, pragueAnnual revenue$100M - $200MTotal visits22.7KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Sanofi Pasteur SA

These are the website technologies, by industry, used by Sanofi Pasteur SA top domains

Conversion & Analytics (5)

Google Analytics

Social (5)

Instagram

Advertising (3)

LinkedIn Advertiser

Payment & Currencies (3)

Cart Functionality

More Technologies

8

See all

News & Signals from Sanofi Pasteur SA

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSinobiopharm sold assets to Sanofi SA in the amount of $1.53B on Jun 1st '26.Sanofi recently acquired global rights to rovadicitinib from Sino Biopharmaceutical for up to USD 1.53 billion, a JAK/ROCK inhibitor targeting the same disease, illustrating the competitive intensity around novel myelofibrosis assets.

NewsSanofi SA increased headcount by 18 on Jun 26th '26.There will be 18 new jobs once the equipment is operational, said Rakesh Kakkar, Sanofi's vice president and head of manufacturing and supply.

NewsSanofi SA invested into assets: campus in the amount of $1.3B in Pennsylvania, United States, Northern America, Americas on Jun 26th '26."For 15 years, Sanofi has invested more than $1.3 billion in capital investment into its Swiftwater campus and today's grant builds on that legacy of investment - not just expanding output, but in making the operation cleaner and more sustainable for the long term," said Monroe County Commissioner John Christy.